http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015160204-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a088303190a641c081d49857253251b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
filingDate 2015-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bac9be0dafce195e91fc894ac334eab2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_197dc0ada04e4c34e67bd898a3805ba4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1db1b969e107ea972514643e59ef19c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56e62970d29286093ce97e2cd51eb2be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_817878ce96e91d5b59d5055de8442506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7ddc627f55c7eb4024d49088a46f74b
publicationDate 2015-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2015160204-A1
titleOfInvention Orally administered pharmaceutical composite formulation containing bisoprolol and rosuvastatin
abstract The present invention relates to an orally administered pharmaceutical composite formulation containing bisoprolol and rosuvastatin and a method for manufacturing same. The orally administered pharmaceutical composite formulation, according to the present invention, effectively prevents and treats hypertension, angina, and hypercholesterolemia, and the reduction in stability of the formulation is improved by a reaction between two active ingredients, which provides excellent storage stability, thereby improving drug administration convenience of the patient and being useful in the treatment of hypertension, angina, and hypercholesterolemia.
priorityDate 2014-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20080092436-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120105317-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20080077033-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20090014183-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226753552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129477689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10892731
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282455

Total number of triples: 38.